Jun 9, 2023, 02:54
The field of BPDCN is rapidly evolving – Hagop Kantarjian
The field of BPDCN is rapidly evolving.
Our new article by Dr. Pemmaraju highlights the new era of targeting CD123 in combinations & beyond.
https://pubmed.ncbi.nlm.nih.gov/37145496/
Source: Hagop Kantarjian / Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14